BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34726569)

  • 1. The pharmacokinetic study on the interaction between nobiletin and anemarsaponin BII
    Zhang J; Fan M; Yu X; Zhang B
    Pharm Biol; 2021 Dec; 59(1):1528-1532. PubMed ID: 34726569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
    Wang M; Jiang W; Zhou J; Xue X; Yin C
    Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein inhibits the pharmacokinetics of simvastatin in rats
    Meng M; Li X; Zhang X; Sun B
    Pharm Biol; 2021 Dec; 59(1):880-883. PubMed ID: 34214011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glycyrrhizin on the pharmacokinetics of nobiletin in rats and its potential mechanism.
    Wang H; Dong L; Qu F; He H; Sun W; Man Y; Jiang H
    Pharm Biol; 2020 Dec; 58(1):352-356. PubMed ID: 32298152
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic interaction between peimine and paeoniflorin in rats and its potential mechanism.
    Chen Q; Yin C; Li Y; Yang Z; Tian Z
    Pharm Biol; 2021 Dec; 59(1):129-133. PubMed ID: 33721550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
    Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
    Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats.
    Sun S; Liu L; Song H; Li H
    Pharm Biol; 2022 Dec; 60(1):1944-1948. PubMed ID: 36226863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism.
    Shang H; Wang Z; Ma H; Sun Y; Ci X; Gu Y; Liu C; Si D
    Pharm Biol; 2021 Dec; 59(1):200-208. PubMed ID: 33595422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.
    Wang X; Zhang X; Liu F; Wang M; Qin S
    Pharm Biol; 2017 Dec; 55(1):1863-1867. PubMed ID: 28614959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of the interaction between luteolin and magnoflorine in rats.
    Liu L; Li X
    Chem Biol Drug Des; 2024 Jan; 103(1):e14356. PubMed ID: 37731180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism.
    Zhang J; Liu L; Li H; Zhang B
    Pharm Biol; 2021 Dec; 59(1):1256-1259. PubMed ID: 34517743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats.
    Liu W; Liu G; Liu J
    Pharm Biol; 2019 Dec; 57(1):449-452. PubMed ID: 31290355
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ophiopogonin D on the pharmacokinetics and transport of cryptotanshinone during their co-administration and the potential mechanism.
    Wang L; Gu H; Chen K
    Chem Biol Drug Des; 2023 Sep; 102(3):557-563. PubMed ID: 37291736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and verification of CYP3A4 inhibitors from Bushen-Yizhi formula to enhance the bioavailability of osthole in rat plasma.
    Liu JM; Chen JM; Lin MJ; Wu FC; Ma CR; Zuo X; Yu WQ; Huang MJ; Fang JS; Li WR; Wang Q; Liang Y
    J Ethnopharmacol; 2022 Jan; 282():114643. PubMed ID: 34534597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of Cucurbitacin E related hepatotoxicity and drug-drug interactions involving CYP3A and P-glycoprotein.
    Lu J; Zhang Y; Sun M; Liu M; Wang X
    Phytomedicine; 2017 Mar; 26():1-10. PubMed ID: 28257659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and
    Meng Q; Cheng Y; Zhou C
    Pharm Biol; 2021 Dec; 59(1):1551-1555. PubMed ID: 34757861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saikosaponins and the deglycosylated metabolites exert liver meridian guiding effect through PXR/CYP3A4 inhibition.
    Liu Q; Xue Y; Liu J; Ren S; Xu J; Yang J; Xing Y; Zhang Z; Song R
    J Ethnopharmacol; 2021 Oct; 279():114344. PubMed ID: 34147617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study on the interaction between succinic acid and irbesartan in rats and its potential mechanism.
    Wang Y; Rui R; Zhang X; Sun B
    Pharm Biol; 2021 Dec; 59(1):1619-1622. PubMed ID: 34818122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory Effect of Oxethazaine on Midazolam Metabolism in Rats.
    Namba H; Nishimura Y; Kurata N; Iwase M; Hirai T; Kiuchi Y
    Biol Pharm Bull; 2017; 40(9):1361-1365. PubMed ID: 28867721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism.
    Zhang H; Song J; Dai H; Liu Y; Wang L
    Pharm Biol; 2020 Dec; 58(1):328-332. PubMed ID: 32356474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.